Oraya Therapeutics

Oraya Therapeutics was founded in 2007 with an initial investment from Essex Woodlands Health Ventures. Four leading healthcare investment firms back us.

Domain invests primarily in young life science focused businesses with outstanding growth potential. Over its 20-year history, Domain has been involved in the creation of more than 200 companies. Its latest venture capital fund is Domain Partners VIII, which is capitalized at $500 million. Domain is located in Princeton, New Jersey and in Laguna Niguel, California.

Established in 1985, Essex Woodlands is one of the most respected and successful healthcare venture capital and growth equity firms in the world. Essex currently has $2.5 billion under management and is investing out of its eighth fund of $900 million, which closed in 2009.

Synergy Life Science Partners is a venture capital firm that helps to form and invest in early stage medical device and combination product (device with a therapeutic payload such as biologics and drugs) companies. The firm takes a synergistic approach with entrepreneurs to build valuable companies through capital allocation, access to its valuable network, and its technical, clinical, and operational expertise.

Back To Top

© 2014 All rights reserved. Oraya Therapeutics, Inc. The IRay® is a CE-marked medical device. The IRay is not available for sale in the United States. For additional details, including safety and risk information, please see the ORAYA THERAPY section of this website. Oraya, Oraya Therapy, IRay and I-Guide are either trademarks or registered trademarks of Oraya Therapeutics, Inc. in the United States and other countries.